(1 month, 2 weeks ago)
Commons ChamberI welcome the hon. Gentleman, following his election, to his position as Chair of the Backbench Business Committee. I know what fantastic work he did as Vice-Chair of the Committee in the previous Parliament, as he and I were in these sessions together for many hours. I look forward to working with him, and have already been in touch with him to fix up a meeting at the earliest opportunity, so that we can table forthcoming business in the Chamber. We will absolutely work at pace to populate the Committees and get them up and running as quickly as possible.
We announced in the King’s Speech that we would take forward the Tobacco and Vapes Bill, which will come to the House in due course. One issue that the Secretary of State is considering is how to strengthen the Bill before we introduce it by looking at amendments from the previous Session.
May I say how good it is to see my right hon. Friend in her role as Leader of the House?
The Competition and Markets Authority, backed by the Court of Appeal, found that pharmaceutical firms Auden McKenzie and Actavis UK charged excessive and unfair prices for hydrocortisone tablets. NHS spending on those products rose from around £500,000 to over £80 million a year. Producers gaming the system to gouge the NHS is a bad look. Tens of thousands of people depend on those tablets to treat conditions such as Addison’s disease. May we have a statement on NHS procurement? Our new plan for procurement must prevent bad actors from ripping off our NHS.
I thank my hon. Friend for his kind words. It is a pleasure to continue working with him in this new Session, as I did so closely in the last. He is a real champion for transparency, accountability and value for money in government, and he raises those important matters today. He may wish to raise them after business questions, during the statement on the NHS audits that have just been carried out, as procurement is a key part of those findings.